Atlas Trials

Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma

Clinical trial NCT03376932 · WITHDRAWN

Trial details

NCT number
NCT03376932
Sponsor
GlaxoSmithKline
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Asthma
Start date
2019-01-18
Primary completion
2021-02-03
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.